Role of ChatGPT in Vestibular Schwannoma Management
Launched by UNIVERSITY OF SOUTHERN CALIFORNIA · Nov 30, 2023
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how using ChatGPT, a conversational computer program, can help patients with vestibular schwannoma—a type of benign tumor that affects the vestibular nerve—make better decisions about their treatment. Many patients face confusion and uncertainty when making important medical choices, and this study aims to see if ChatGPT can ease that decision-making stress. Participants will be divided into two groups: one will receive training on how to use ChatGPT for support, while the other will not. Researchers will measure how each group feels about their decisions before and after using the tool.
To take part in this study, you must be at least 18 years old and have been diagnosed with vestibular schwannoma. You’ll also need access to a device that can connect to the internet and run ChatGPT. If you join, you can expect to share your thoughts on your decision-making experience, which will help researchers understand if ChatGPT is a useful tool for patients. This study is not yet recruiting, so keep an eye out for updates if you're interested!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years or older
- • Diagnosed with vestibular schwannoma
- • Have access to internet-enabled device that is compatible with ChatGPT
- Exclusion Criteria:
- • \< 18 years old
- • patient without diagnosis of vestibular schwannoma
- • patient does not have access to internet-enabled device
- • patient who declines study participation
About University Of Southern California
The University of Southern California (USC) is a prestigious research institution located in Los Angeles, California, known for its commitment to advancing knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, USC leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct cutting-edge research aimed at improving patient outcomes and public health. The university fosters collaboration among its diverse faculty and students, ensuring a dynamic environment for the development and implementation of clinical studies that adhere to the highest ethical and scientific standards. Through its clinical trials, USC aims to contribute to the advancement of medical science and the translation of research findings into practical applications that benefit communities locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported